If you invested in Medical Propoerties Trust and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses »
05/23/2023 - 08/17/2023
LEAD PLAINTIFF DEADLINE
The litigation focuses on the propriety of Medical Properties Trust’s statements about its recapitalization transaction (“Recap Transaction”) with its third largest tenant, Prospect Medical Holdings.
The complaint alleges Medical Properties Trust misrepresented and failed to disclose that: (i) the Recap Transaction was subject to regulatory approval and (ii) on or about July 20, 2023, the company had received an order from the California’s Department of Managed Health Care (“DMHC”) placing the transaction on hold.
Investors learned the truth on Aug. 18, 2023, when the Wall Street Journal reported on Medical Properties Trust and, referring to the Recap Transaction, said that “[t]he nation’s largest hospital landlord said an unusual transaction that provided crucial financial support for one of its biggest tenants was a done deal” and “[i]t wasn’t.” The WSJ further reported that on Aug. 8, 2023, the company said the transaction boosted its revenue while in possession of an order by a California state regulator putting the transaction on hold and observed that Medical Properties Trust did not disclose the regulator’s order when it filed its quarterly earnings report.
In response, the price of Medical Properties Trust shares fell significantly lower on Aug. 18, 2023.
If you invested in Medical Properties Trust and have significant losses, or have knowledge that may assist the firm’s investigation, submit your losses.
Whistleblowers: Persons with non-public information regarding Medical Properties Trust should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email MPW@hbsslaw.com.
FREQUENTLY ASKED QUESTIONS ABOUT THE CASE
- What is the MPW securities class-action case about?
This lawsuit on behalf of investors nationwide focuses on the propriety of Medical Properties Trust's statements about its recapitalization transaction (“Recap Transaction”) with its third largest tenant, Prospect Medical Holdings.
WHAT SHOULD I DO?
- I worked at MPW. What should I do?
If you were an employee of MPW during the period relevant to the class-action case, you may have valuable information that could be relevant to the lawsuit. Hagens Berman is one of the nation’s top whistleblower law firms, and has successfully represented many individuals who come forward with information regarding corporate malfeasance. Under the new SEC Whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, contact Reed Kathrein at 844-916-0895 or MPW@hbsslaw.com.
- There are multiple law firms participating, do I need to contact all of them?
No, you do not need to contact all participating law firms. Generally, class-action lawsuits are consolidated into a single case to streamline the legal process, and attorneys from only a few law firms are selected to serve in a leadership role on the consolidated case. Hagens Berman has a proven track record of being appointed to leadership roles in complex, multidistrict litigation regarding investor fraud and other consumer rights issues, and your claim will be handled by attorneys who have helped secure approximately $325 billion in class-action settlements on behalf of individuals who have suffered due to corporate malfeasance and the wrongdoing of other powerful institutions
AM I ELIGIBLE?
- What is the threshold amount to be eligible? What are “substantial” losses?
The threshold amount and the definition of "substantial" losses may vary depending on a number of factors specific to the case, including the size of the company, market cap, shares outstanding and who holds them and the damages alleged by the fraud. In general, to be eligible to participate in a class-action lawsuit, you must be able to demonstrate that you suffered financial losses as a result of the alleged wrongdoing and that your losses meet the criteria set by the court or law firm. Fill out the form and submit your losses.
CAN I PARTICPATE?
- Am I affected? What do I need to do to participate?
If you were an investor in MPW during the relevant period specified in the class-action lawsuit, you may be affected and eligible to participate in the case. To determine your eligibility and potential involvement, fill out the form and submit your losses.
- Can any MPW investor participate?
In most class-action cases, any investor who meets the eligibility criteria, including purchasing the shares during the relevant period, can participate, regardless of the size of their investment. Fill out the form to find out your rights.
- I bought on a non-U.S. Exchange. Can I participate?
No. This class-action only covers shares bought on a U.S. exchange, i.e. NASDAQ or NYSE. Fill out the form to find out your rights.
- Am I included if I still hold my shares, or do I need to sell to participate?
Participation is based on purchasing shares during the relevant period, rather than your current holdings. Accordingly, you do not need to sell to participate. Fill out the form to find out your rights.